Clinical and hematological profile of patients with philadelphia-negative myeloproliferative neoplasms: First report from the Ecuadorian registry. [PDF]
Hematol Transfus Cell TherFreire C +8 more
europepmc +1 more source
Mutant calreticulin-Cancer driver and Achilles' heel for ET? [PDF]
HemasphereReichert M, Psaila B.
europepmc +1 more source
SF3B1 mutation as a predictive biomarker for luspatercept efficacy in myeloproliferative neoplasms and MDS/MPN: a clinical study. [PDF]
Ann HematolCui T +6 more
europepmc +1 more source
Symptom burden and palliative care in patients with hematologic malignancies: a single-center experience. [PDF]
Support Care CancerHolopainen A +3 more
europepmc +1 more source
JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms. [PDF]
LeukemiaKealy D +27 more
europepmc +1 more source
PD-1/PD-L1-CXCR3 Coexpression and CXCR3 on Intermediate Monocytes Predict Fibrosis, Leukemic Transformation, and Survival in Egyptian Philadelphia-Negative Myeloproliferative Neoplasms. [PDF]
Clin Med Insights OncolSherief DE +5 more
europepmc +1 more source
Translation and Validation of Myeloproliferative Neoplasm-Symptom Assessment Form (MPN-SAF)-Total Symptom Score (MPN-SAF TSS) Filipino Version. [PDF]
Acta Med PhilippMesina FZ, de Castro JAV, Alejandria MM.
europepmc +1 more source